Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis

Journal of Clinical Investigation

Volumn 116, Issue 3, 2006, Pages 683-694

  Menon, Madhu P ^a   Karur, Vinit ^a   Bogacheva, Olga ^a   Bogachev, Oleg ^a   Cuetara, Bethany ^a   Wojchowski, Don M ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; ERYTHROPOIETIN RECEPTOR; FLUOROURACIL; GENE PRODUCT; ONCOSTATIN M; PHOSPHOTYROSINE; PROTEIN BCL X; PROVIRAL INTEGRATION SITE 1 KINASE; SCATTER FACTOR; STAT5 PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL GROWTH; CELL LOSS; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR GENE; STRESS;

ANEMIA; ANIMALS; BINDING SITES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; ERYTHROBLASTS; ERYTHROPOIESIS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHENYLHYDRAZINES; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 33644647514     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25227     Document Type: Article

References (54)

1. Wu, H., Liu, X., Jaenisch, R., and Lodish, H.F. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:59-67.
2. Warnecke, C., et al. 2004. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 18:1462-1464.
3. Richmond, T.D., Chohan, M., and Barber, D.L. 2005. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol. 15:146-155.
4. Livnah, O., et al. 1999. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 283:987-990.
5. Smith, R. 2002. Applications of darbepoietin-alpha, a novel erythropoiesis-stimulating protein, in oncology. Curr. Opin. Hematol. 9:228-233.
6. List, A., et al. 2005. Efficacy of lenalidomide in myelodysplastic syndromes. N. Engl. J. Med. 352:549-557.
7. Lacombe, C. 1996. Resistance to erythropoietin. N. Engl. J. Med. 334:660-662.
8. Gordeuk, V.R., Stockton, D.W., and Prchal, J.T. 2005. Congenital polycythemias/erythrocytoses. Haematologica. 90:109-116.
9. Livnah, O., et al. 1996. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science. 273:464-471.
10. Maiese, K., Li, F., and Chong, Z.Z. 2005. New avenues of exploration for erythropoietin. JAMA. 293:90-95.
11. Sadoff, L. 2005. Erythropoietin and cancer. JAMA. 293:1858; author reply 1858-1859.
12. Klingmuller, U., Lorenz, U., Cantley, L.C., Neel, B.G., and Lodish, H.F. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:729-738.
13. Hortner, M., Nielsch, U., Mayr, L.M., Heinrich, P.C., and Haan, S. 2002. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur. J. Biochem. 269:2516-2526.
14. Wormald, S., and Hilton, D.J. 2004. Inhibitors of cytokine signal transduction. J. Biol. Chem. 279:821-824.
15. Mason, J.M., Beattie, B.K., Liu, Q., Dumont, D.J., and Barber, D.L. 2000. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor. J. Biol. Chem. 275:4398-4406.
16. Klingmuller, U., et al. 1997. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. U. S. A. 94:3016-3021.
17. Jaster, R., Bittorf, T., and Brock, J. 1997. Involvement of phosphatidylinositol 3-kinase in the mediation of erythropoietin-induced activation of p70S6k. Cell. Signal. 9:175-179.
18. Tauchi, T., et al. 1996. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood. 87:4495-4501.
19. Tong, Q., et al. 2004. Erythropoietin-modulated calcium influx through TRPC2 is mediated by phospholipase Cgamma and IP3R. Am. J. Physiol. Cell Physiol. 287:C1667-C1678.
20. Lecoq-Lafon, C., et al. 1999. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood. 93:2578-2585.
21. Bittorf, T., Buchse, T., Sasse, T., Jaster, R., and Brock, J. 2001. Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance. Cell. Signal. 13:673-681.
22. Damen, J.E., et al. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
23. Socolovsky, M., Fallon, A.E., Wang, S., Brugnara, C., and Lodish, H.F. 1999. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 98:181-191.
24. Zon, L.I. 2002. Hematopoietic development in the zebrafish [abstract]. Blood. 100:A58.
25. Zang, H., et al. 2001. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 20:3156-3166.
26. Lenox, L.E., Perry, J.M., and Paulson, R.F. 2004. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood. 105:2741-2748.
27. Angelillo-Scherrer, A., et al. 2004. Critical amplification by Gas6 of the Epo-dependent erythropoietic response to anemia: novel opportunities for anemia treatment [abstract]. Blood. 104:A459.
28. Tanaka, M., et al. 2003. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood. 102:3154-3162.
29. Li, K., Menon, M.P., Karur, V.G., Hegde, S., and Wojchowski, D.M. 2003. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells. Blood. 102:3147-3153.
30. Socolovsky, M., et al. 2001. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood. 98:3261-3273.
31. Divoky, V., et al. 2001. Mouse model of congenital polycythemia: homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proc. Natl. Acad. Sci. U. S. A. 98:986-991.
32. Suzuki, N., et al. 2003. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood. 102:3575-3583.
33. Dormer, P., Spitzer, E., Frankenberger, M., and Kremmer, E. 2004. Erythroid differentiation regulator (EDR), a novel, highly conserved factor. I. Induction of haemoglobin synthesis in erythroleukaemic cells. Cytokine. 26:231-242.
34. Pircher, T.J., Zhao, S., Geiger, J.N., Joneja, B., and Wojchowski, D.M. 2000. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene. 19:3684-3692.
35. Cacalano, N.A., Sanden, D., and Johnston, J.A. 2001. Tyrosine- phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3:460-465.
36. Hammerman, P.S., Fox, C.J., Birnbaum, M.J., and Thompson, C.B. 2005. The Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood. 105:4477-4483.
37. Fox, C.J., Hammerman, P.S., and Thompson, C.B. 2005. The Pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med. 201:259-266.
38. Fox, C.J., et al. 2003. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 17:1841-1854.
39. Wu, H., Klingmuller, U., Besmer, P., and Lodish, H.F. 1995. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 377:242-246.
40. Jacobs-Helber, S.M., Penta, K., Sun, Z., Lawson, A., and Sawyer, S.T. 1997. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 272:6850-6853.
41. Li, K., Miller, C., Hegde, S., and Wojchowski, D. 2003. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit. J. Biol. Chem. 278:40702-40709.
42. Kirito, K., et al. 2002. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood. 99:102-110.
43. Brizzi, M.F., Dentelli, P., Rosso, A., Yarden, Y., and Pegoraro, L. 1999. STAT protein recruitment and activation in c-Kit deletion mutants. J. Biol. Chem. 274:16965-16972.
44. Shay, K.P., Wang, Z., Xing, P.X., McKenzie, I.F., and Magnuson, N.S. 2005. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol. Cancer Res. 3:170-181.
45. Arcasoy, M.O., and Jiang, X. 2005. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor. Br. J. Haematol. 130:121-129.
46. Blanchard, F., et al. 2001. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J. Biol. Chem. 276:47038-47045.
47. Gobert, S., et al. 1996. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15:2434-2441.
48. Halupa, A., et al. 2005. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood. 105:552-561.
49. Matsumoto, A., et al. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood. 89:3148-3154.
50. Yoshimura, A., et al. 1996. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 15:1055-1063.
51. Jegalian, A.G., and Wu, H. 2002. Differential roles of SOCS family members in EpoR signal transduction. J. Interferon Cytokine Res. 22:853-860.
52. Wagner, K.U., et al. 2000. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development. 127:4949-4958.
53. Russell, E.S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20:357-459.
54. Quelle, F.W., et al. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16:1622-1631.